Search research articles
Contact Us
Filters
Showing results (101-110 of 223) with videos related to
Page
of 23
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
Plos One
|
May 2, 2013
A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity
Stephen J Pettitt, Farah L Rehman, Ilirjana Bajrami, et al.
Diabetes
|
December 28, 2002
The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome
Frances A Brook, Edward P Evans, Christopher J Lord, et al.
British Journal of Cancer
|
May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma
Katharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
The Journal of Pathology
|
July 8, 2011
Functional characterization of EMSY gene amplification in human cancers
Paul M Wilkerson, Konstantin J Dedes, Daniel Wetterskog, et al.
The Journal of Biological Chemistry
|
June 9, 2016
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma
Daniel Beck, Jenny Zobel, Ruth Barber, et al.
Breast Cancer Research : BCR
|
December 11, 2007
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
Matthew J Smalley, Marjan Iravani, Maria Leao, et al.
The Journal of Pathology
|
August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model
Sarah L Maguire, Barrie Peck, Patty T Wai, et al.
Stem Cells (Dayton, Ohio)
|
June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers
Anna L Stratford, Kristen Reipas, Kaiji Hu, et al.
Plos One
|
March 10, 2012
A modified method for whole exome resequencing from minimal amounts of starting DNA
Iwanka Kozarewa, Juan Manuel Rosa-Rosa, Christopher P Wardell, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 223) with videos related to
Sort By:
Page
of 23
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
Plos One
|
May 2, 2013
A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity
Stephen J Pettitt, Farah L Rehman, Ilirjana Bajrami, et al.
Diabetes
|
December 28, 2002
The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome
Frances A Brook, Edward P Evans, Christopher J Lord, et al.
British Journal of Cancer
|
May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma
Katharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
The Journal of Pathology
|
July 8, 2011
Functional characterization of EMSY gene amplification in human cancers
Paul M Wilkerson, Konstantin J Dedes, Daniel Wetterskog, et al.
The Journal of Biological Chemistry
|
June 9, 2016
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma
Daniel Beck, Jenny Zobel, Ruth Barber, et al.
Breast Cancer Research : BCR
|
December 11, 2007
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
Matthew J Smalley, Marjan Iravani, Maria Leao, et al.
The Journal of Pathology
|
August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model
Sarah L Maguire, Barrie Peck, Patty T Wai, et al.
Stem Cells (Dayton, Ohio)
|
June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers
Anna L Stratford, Kristen Reipas, Kaiji Hu, et al.
Plos One
|
March 10, 2012
A modified method for whole exome resequencing from minimal amounts of starting DNA
Iwanka Kozarewa, Juan Manuel Rosa-Rosa, Christopher P Wardell, et al.
Page
of 23